237 related articles for article (PubMed ID: 16175714)
1. New guidance on reviews by central institutional review boards (IRBs).
Maloney DM
Hum Res Rep; 2005 May; 20(5):1-2. PubMed ID: 16175714
[No Abstract] [Full Text] [Related]
2. New federal guidance adds duties for institutional review boards (IRBs).
Maloney DM
Hum Res Rep; 2005 Nov; 20(11):1-2. PubMed ID: 16358479
[No Abstract] [Full Text] [Related]
3. A study of warning letters issued to institutional review boards by the United States Food and Drug Administration.
Bramstedt KA; Kassimatis K
Clin Invest Med; 2004 Dec; 27(6):316-23. PubMed ID: 15675112
[TBL] [Abstract][Full Text] [Related]
4. New guidelines for institutional review boards stress special role.
Maloney DM
Hum Res Rep; 2000 Dec; 15(12):1-2. PubMed ID: 11789516
[No Abstract] [Full Text] [Related]
5. Use of central institutional review boards for multicenter clinical trials in the United States: a review of the literature.
Check DK; Weinfurt KP; Dombeck CB; Kramer JM; Flynn KE
Clin Trials; 2013 Aug; 10(4):560-7. PubMed ID: 23666951
[TBL] [Abstract][Full Text] [Related]
6. HIPAA and what institutional review boards (IRBs) do not have to review.
Maloney DM
Hum Res Rep; 2003 Dec; 18(12):1-2. PubMed ID: 15027429
[No Abstract] [Full Text] [Related]
7. The role of institutional review boards in protecting human subjects: are we really ready to fix a broken system?
Beh HG
Law Psychol Rev; 2002; 26(1):1-47. PubMed ID: 16514756
[No Abstract] [Full Text] [Related]
8. Reducing the burden on many institutional review boards.
Maloney DM
Hum Res Rep; 2003 Jun; 18(6):1-2. PubMed ID: 15119341
[No Abstract] [Full Text] [Related]
9. New review burdens will affect many institutional review boards (IRBs).
Maloney DM
Hum Res Rep; 2001 Jul; 16(7):9. PubMed ID: 11933956
[No Abstract] [Full Text] [Related]
10. Institutional review boards and institutions not doing enough to protect human subjects.
Maloney DM
Hum Res Rep; 2000 Jun; 15(6):1-3. PubMed ID: 12199292
[No Abstract] [Full Text] [Related]
11. Views of the process and content of ethical reviews of HIV vaccine trials among members of US institutional review boards and South African research ethics committees.
Klitzman R
Dev World Bioeth; 2008 Dec; 8(3):207-18. PubMed ID: 19046258
[TBL] [Abstract][Full Text] [Related]
12. Institutional review boards (IRBs) would have an increased role in international research.
Maloney DM
Hum Res Rep; 2002 Oct; 17(10):9. PubMed ID: 12731498
[No Abstract] [Full Text] [Related]
13. Medical research oversight from the corporate governance perspective: comparing institutional review boards and corporate boards.
Saver RS
William Mary Law Rev; 2004 Nov; 46(2):619-730. PubMed ID: 17167924
[No Abstract] [Full Text] [Related]
14. Alternatives to local institutional review board (IRB) system debated.
Maloney DM
Hum Res Rep; 2006 Apr; 21(4):1-2. PubMed ID: 16832918
[No Abstract] [Full Text] [Related]
15. Institutional review boards (IRBs) and working with adverse event reports.
Maloney DM
Hum Res Rep; 2005 Dec; 20(12):1-3. PubMed ID: 16607708
[No Abstract] [Full Text] [Related]
16. Institutional review boards (IRBs) and risk considerations for children.
Maloney DM
Hum Res Rep; 2004 Sep; 19(9):1-3. PubMed ID: 15675081
[No Abstract] [Full Text] [Related]
17. How institutional review boards (IRBs) can handle adverse event reports.
Maloney DM
Hum Res Rep; 2006 Jan; 21(1):1-3. PubMed ID: 16789305
[No Abstract] [Full Text] [Related]
18. Central IRBs: why are some institutions reluctant to sign on?
McNeil C
J Natl Cancer Inst; 2005 Jul; 97(13):953-5. PubMed ID: 15998943
[No Abstract] [Full Text] [Related]
19. Institutional review board guidance on pediatric research: missed opportunities.
Wolf LE; Zandecki J; Lo B
J Pediatr; 2005 Jul; 147(1):84-9. PubMed ID: 16027701
[TBL] [Abstract][Full Text] [Related]
20. Continued concern: human subject protection, the institutional review board, and continuing review.
Hoffman S
Tenn Law Rev; 2001; 68(4):725-70. PubMed ID: 16189912
[No Abstract] [Full Text] [Related]
[Next] [New Search]
